Loading...

NeuroPace, Inc.

NPCE•NASDAQ
Healthcare
Medical - Devices
$8.65
$-0.34(-3.78%)

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.4/100

Key Financials

Market Cap286.2M
P/E Ratio-16.66
EPS (TTM)$-0.82
ROE-1.12%
Fundamental Analysis

AI Price Forecasts

1 Week$14.40
1 Month$12.71
3 Months$16.27
1 Year Target$14.03

NPCE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroPace, Inc. (NPCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.66 and a market capitalization of 286.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.83%
5-Day Change
-14.19%
1-Month Change
5.98%
3-Month Change
-10.89%
6-Month Change
71.34%
Year-to-Date (YTD) Change
-8.12%
1-Year Change
-26.72%
3-Year Change
34.85%
5-Year Change
-57.37%
All-Time (Max) Change
-57.37%

Contact Information

https://www.neuropace.com
650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

184 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;